AccuStem Sciences, Inc. (ACUT)
OTCMKTS · Delayed Price · Currency is USD
0.280
0.00 (0.00%)
At close: Apr 24, 2026

AccuStem Sciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020
Net Income
-1.76-1.51-2.05-3.75-0.67
Upgrade
Depreciation & Amortization
0000-
Upgrade
Stock-Based Compensation
0.170.30.080.130.02
Upgrade
Other Operating Activities
----0.07-
Upgrade
Change in Accounts Receivable
---1.35-
Upgrade
Change in Accounts Payable
-0.10.230.27-0.080.39
Upgrade
Change in Other Net Operating Assets
0.840.310.090.590.25
Upgrade
Operating Cash Flow
-0.85-0.66-1.62-1.81-
Upgrade
Capital Expenditures
----0.01-
Upgrade
Investing Cash Flow
----0.01-
Upgrade
Short-Term Debt Issued
0.960.781.25--
Upgrade
Total Debt Issued
0.960.781.25--
Upgrade
Short-Term Debt Repaid
-0.1-0.13-0.34-0.34-
Upgrade
Total Debt Repaid
-0.1-0.13-0.34-0.34-
Upgrade
Net Debt Issued (Repaid)
0.860.650.9-0.34-
Upgrade
Issuance of Common Stock
---2.89-
Upgrade
Financing Cash Flow
0.860.650.92.55-
Upgrade
Net Cash Flow
0.01-0.02-0.710.73-
Upgrade
Free Cash Flow
-0.85-0.66-1.62-1.82-
Upgrade
Free Cash Flow Per Share
-0.06-0.06-0.14-0.17-
Upgrade
Cash Interest Paid
000.010.01-
Upgrade
Levered Free Cash Flow
0.670.580.11-0.790.26
Upgrade
Unlevered Free Cash Flow
0.670.580.11-0.790.26
Upgrade
Change in Working Capital
0.740.530.351.870.65
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.